In Vivo Functions Of Isgylation

Subcellular Biochemistry

Volumn 54, Issue , 2010, Pages 215-227

  Knobeloch, Klaus Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

CYTOKINE; INTERFERON; UBIQUITIN;

ANIMAL; GENETICS; METABOLISM;

ANIMALS; CYTOKINES; INTERFERONS; UBIQUITIN; UBIQUITINS;

EID: 84867744338     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6676-6_17     Document Type: Article

References (61)

1. Haas AL, Ahrens P, Bright PM et al. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 1987; 262:11315-23.
2. D'Cunha J, Knight E Jr, Haas AL et al. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc NatlAcad Sci USA 1996; 93:211-5.
3. D'Cunha J, Ramanujam S, Wagner RJ et al. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 1996; 157:4100-8.
4. Padovan E, Terracciano L, Certa U et al. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res 2002; 62:3453-8.
5. Ritchie KJ, Zhang DE. ISG15: the immunological kin of ubiquitin. Seminars in Cell and Developmental Biology 2004; 15:237-46.
6. Haas AL, Ahrens P, Bright PM et al. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 1987; 262:11315-23.
7. Yuan WM, Krug RM. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO Journal 2001; 20:362-71.
8. Zhao C, Beaudenon SL, Kelley ML et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci USA 2004; 101:7578-82.
9. Takeuchi T, Iwahara S, Saeki Yet al. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme. J Biochem 2005; 138:711-9.
10. Wong JJY, Pung YF, Sze NSK et al. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation ofprotein targets. Proc Natl Acad Sci USA 2006; 103:10735-40.
11. Dastur A, Beaudenon S, Kelley M et al. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation ofISG15 in human cells. J Biol Chem 2006; 281:4334-8.
12. Zou WG, Zhang DE. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 2006; 281:3989-94.
13. Zou W, Wang J, Zhang DE. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation. Biochem Biophys Res Commun 2007; 354:321-7.
14. Okumura F, Zou W, Zhang DE. ISG15 modification ofthe eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev 2007; 21:255-60.
15. Wong JJY, Pung YF, Sze NSK et al. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation ofprotein targets. Proc Natl Acad Sci USA 2006; 103:10735-40.
16. Dastur A, Beaudenon S, Kelley M et al. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation ofISG15 in human cells. J Biol Chem 2006; 281:4334-8.
17. Liu LQ, Ilaria R, Kingsley PD et al. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol Cell Biol 1999; 19:3029-38.
18. Schwer H, Liu LQ, Zhou LM et al. Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18). Genomics 2000; 65:44-52.
19. Malakhov MP, Malakhova OA, Kim KI et al. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 2002; 277:9976-81.
20. Catic A, Fiebiger E, Korbel GA et al. Screen for ISG15-crossreactive deubiquitinases. PLoS ONE 2007; 2:e679.
21. Yuan WM, Krug RM. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 2001; 20:362-71.
22. Okumura A, Lu GS, Pitha-Rowe I et al. Innate antiviral response targets HIV-1 release by the induction ofubiquitin-like protein ISG15. Proc Natl Acad Sci USA 2006; 103:1440-5.
23. Giannakopoulos NV, Luo JK, Papov V et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005; 336:496-506.
24. Zhao C, Denison C, Huibregtse JM et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005; 102:10200-5.
25. Ritchie KJ, Malakhov MP, Hetherington CJ et al. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev 2002; 16:2207-12.
26. Potter JL, Narasimhan J, Mende-Mueller L et al. Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein. J Biol Chem 1999; 274:25061-8.
27. Malakhova OA, Yan M, Malakhov MP et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes and Development 2003; 17:455-60.
28. Ritchie KJ, Hahn CS, Kim KI et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nature Medicine 2004; 10:1374-8.
29. Randall G, Chen LM, Panis M et al. Silencing of USP18 potentiates the antiviral activity of interferon againsthepatitis C virus infection. Gastroenterology 2006; 131:1584-91.
30. Malakhova OA, Yan M, Malakhov MP et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes and Development 2003; 17:455-60.
31. Osiak A, Utermohlen O, Niendorf S et al. ISG15, an interferon-stimulated ubiquitin-like protein, is not essentialfor STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005; 25:6338-45.
32. Knobeloch KP, Utermohlen O, Kisser A et al. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype ofUBP43-deficient mice. Mol Cell Biol 2005; 25:11030-4.
33. Kim KI, Yan M, Malakhova O et al. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 2006; 26:472-9.
34. Malakhova OA, Kim KI, Luo JK et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J 2006; 25:2358-67.
35. Yan M, Luo JK, Ritchie KJ et al. Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling. Blood2007; 110:305-12.
36. Osiak A, Utermohlen O, Niendorf S et al. ISG15, an interferon-stimulated ubiquitin-like protein, is not essentialfor STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005; 25:6338-45.
37. Lenschow DJ, Lai C, Frias-Staheli N et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes and Sindbis viruses. Proc Natl Acad Sci USA 2007; 104:1371-6.
38. Hsiang TY, Zhao C, Krug RM. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 2009; 83:5971-7.
39. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8:559-68.
40. Giannakopoulos NV, Arutyunova E, Lai C et al. ISG15 Arg151 andtheISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J Virol 2009; 83:1602-10.
41. Lai C, Struckhoff JJ, Schneider J et al. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and nonmouse-adapted influenza B virus infection. J Virol 2009; 83:1147-51.
42. Pitterle DM, Jolicoeur EM, Bepler G. Hot spots for molecular genetic alterations in lung cancer. In Vivo 1998; 12:643-58.
43. Shah SJ, Blumen S, Pitha-Rowe I et al. UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation. Mol Cancer Ther 2008; 7:905-14.
44. Pitha-Rowe I, Hassel BA, Dmitrovsky E. Involvement ofUBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem 2004; 279:18178-87.
45. Feng Q, Sekula D, Guo Y et al. UBE1L causes lung cancer growth suppression by targeting cyclin D1. Mol Cancer Ther 2008; 7:3780-8.
46. Liu M, Hummer BT, Li X et al. Camptothecin induces the ubiquitin-like protein, ISG15 and enhances ISG15 conjugation in response to interferon. J Interferon Cytokine Res 2004; 24:647-54.
47. Desai SD, Haas AL, Wood LM et al. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006; 66:921-8.
48. Andersen JB, Aaboe M, Borden EC et al. Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer 2006; 94:1465-71.
49. Kiessling A, HogrefeC, Erb S et al. Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene 2009; 28:2606-20.
50. Zou W, Papov V, Malakhova O et al. ISG15 modification ofubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun 2005; 336:61-8.
51. Takeuchi T, Iwahara S, Saeki Y et al. Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme. J Biochemistry 2005; 138:711-9.
52. Jeon YJ, Choi JS, Lee JY et al. Filamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway. Mol Biol Cell 2008; 19:5116-30.
53. Jeon YJ, Choi JS, Lee JY et al. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep 2009; 10:374-80.
54. Malakhova OA, Zhang DE. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 2008; 283:8783-7.
55. Okumura A, Pitha PM, Harty RN. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 2008; 105:3974-9.
56. Malakhova OA, Yan M, Malakhov MP et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 2003; 17:455-60.
57. Ritchie KJ, Hahn CS, Kim KI et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 2004; 10:1374-8.
58. Kim KI, Malakhova OA, Hoebe K et al. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling. J Immunol 2005; 175:847-54.
59. Yan M, Luo JK, Ritchie KJ et al. Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptorsignaling. Blood2007; 110:305-12.
60. Osiak A, Utermohlen O, Niendorf S et al. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling andresponses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005; 25:6338-45.
61. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M. Vaccinia virus E3 protein prevents the antiviral action ofISG15. PLoS Pathog 2008; 4:e1000096.